| Literature DB >> 33918866 |
Hakan Karabiyik1, Mustafa Can Eser1, Ozkan Guler1, Burak Caglar Yasli1,2, Goktug Ertetik1,3, Aysegul Sisman1,4, Mitat Koz1, Tomasz Gabrys5, Karol Pilis6, Raci Karayigit1.
Abstract
Sprint interval training (SIT) is a concept that has been shown to enhance aerobic-anaerobic training adaptations and induce larger effects in hypoxia. The purpose of this study was to examine the effects of 4 weeks of SIT with 15 or 30 s in hypoxia on aerobic, anaerobic performance and critical power (CP). A total of 32 male team players were divided into four groups: SIT with 15 s at FiO2: 0.209 (15 N); FiO2: 0.135 (15 H); SIT with 30 s at FiO2: 0.209 (30 N); and FiO2: 0.135 (30 H). VO2max did not significantly increase, however time-to-exhaustion (TTE) was found to be significantly longer in the post test compared to pre test (p = 0.001) with no difference between groups (p = 0.86). Mean power (MPw.kg) after repeated wingate tests was significantly higher compared to pre training in all groups (p = 0.001) with no difference between groups (p = 0.66). Similarly, CP was increased in all groups with 4 weeks of SIT (p = 0.001) with no difference between groups (p = 0.82). This study showed that 4 weeks of SIT with 15 and 30 s sprint bouts in normoxia or hypoxia did not increased VO2max in trained athletes. However, anerobic performance and CP can be increased with 4 weeks of SIT both in normoxia or hypoxia with 15 or 30 s of sprint durations.Entities:
Keywords: HIIT; chronic training; normobaric hypoxia; sprint duration; team athletes
Year: 2021 PMID: 33918866 PMCID: PMC8069352 DOI: 10.3390/ijerph18083976
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Participant characteristics.
| Parameters | 15 H ( | 15 N ( | 30 H ( | 30 N ( | ||||
|---|---|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | Pre | Post | Pre | Post | |
| Age (years) | 20.75 ± 1.83 | 20.88 ± 1.46 | 20.50 ± 1.31 | 20.13 ± 1.25 | ||||
| Height (cm) | 177.63 ± 8.43 | 177.38 ± 4.75 | 176.88 ± 7.16 | 174.00 ± 7.54 | ||||
| Body Weight (kg) | 66.38 ± 7.75 | 66.90 ± 7.59 | 74.16 ± 9.11 | 75.11 ± 8.54 | 73.61 ± 6.75 | 75.11 ± 8.54 | 72.33 ± 11.10 | 72.49 ± 11.72 |
| Body Fat Percent (%) | 11.11 ± 3.80 | 11.50 ± 2.98 | 13.25 ± 3.54 | 14.10 ± 2.86 | 11.29 ± 4.09 | 11.83 ± 3.93 | 13.55 ± 4.28 | 13.55 ± 4.47 |
| LBM (kg) | 57.68 ± 6.52 | 59.13 ± 6.26 | 64.11 ± 5.91 | 64.38 ± 5.99 | 65.18 ± 4.76 | 64.95 ± 3.91 | 62.18 ± 7.26 | 58.85 ± 7.92 |
| BMI | 20.55 ± 1.52 | 21.14 ± 1.04 | 23.56 ± 2.70 | 23.85 ± 2.42 | 23.55 ± 2.09 | 23.66 ± 2.13 | 23.85 ± 2.92 | 22.69 ± 4.04 |
LBM: Lean body mass; BMI: Body mass index.
Figure 1Schematic diagram of the study summary.
Maximal oxygen consumption test values with related parameters.
| Parameters | 15 H | 15 N | 30 H | 30 N | ||||
|---|---|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | Pre | Post | Pre | Post | |
| VO2mean (ml.kg.min) | 37.23 ± 3.80 | 36.71 ± 3.73 | 37.88 ± 2.52 | 37.97 ± 2.94 | 36.96 ± 4.69 | 37.99 ± 4.82 | 38.13 ± 3.20 | 35.32 ± 7.09 |
| VO2max (ml.kg.min) | 61.15 ± 5.45 | 59.00 ± 6.94 | 59.90 ± 4.73 | 61.49 ± 4.64 | 59.74 ± 7.23 | 59.91 ± 7.36 | 60.84 ± 4.56 | 57.72 ± 9.59 |
| HR at VO2max | 188.17 ± 8.67 | 188.10 ± 7.50 | 190.13 ± 6.14 | 195.55 ± 5.99 | 191.81 ± 5.78 | 191.59 ± 9.31 | 193.39 ± 10.22 | 194.08 ± 10.05 |
| TTE (s) | 1144.5 ± 89.86 | 1193.88 ± 81.54 * | 1100.38 ± 83.80 | 1165.87 ± 69.99 * | 1114.13 ± 73.76 | 1176.25 ± 85.61 * | 1126.13 ± 106.8 | 1198.63 ± 96.09 * |
| RPEmean | 11.92 ± 0.91 | 10.55 ± 1.68 * | 11.60 ± 1.03 | 11.43 ± 1.30 * | 11.58 ± 2.08 | 11.09 ± 1.66 * | 11.91 ± 1.26 | 11.72 ± 1.11 * |
| RPEpeak | 19.25 ± 0.88 | 18.50 ± 2.13 | 19.50 ± 0.75 | 19.12 ± 0.99 | 18.50 ± 2.82 | 18.87 ± 1.80 | 18.87 ± 1.55 | 19.62 ± 0.74 |
| LA (mmol/L) | 10.76 ± 4.21 | 13.51 ± 3.79 * | 13.18 ± 3.62 | 15.69 ± 2.59 * | 11.33 ± 2.74 | 15.48 ± 3.58 * | 12.00 ± 2.97 | 13.84 ± 2.43 * |
HR: heart rate; TTE: time to exhaustion; RPE: ratings of perceived exertion; LA: capillary blood lactate; *: significant difference between pre and post test p < 0.05.
Figure 2VO2max and mean values.
Figure 3Time before exhaustion in VO2max test. *: significant difference between pre and post test.
Repeated wingate and critical power tests.
| Parameters | 15 H | 15 N | 30 H | 30 N | ||||
|---|---|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | Pre | Post | Pre | Post | |
| PP (w/kg) | 9.85 ± 1.40 | 11.32 ± 1.49 * | 9.91 ± 1.49 | 11.25 ± 0.84 * | 9.97 ± 1.18 | 10.89 ± 1.43 * | 9.62 ± 1.53 | 10.65 ± 0.62 * |
| MP (w/kg) | 6.67 ± 0.70 | 7.20 ± 0.48 * | 6.40 ± 0.67 | 7.33 ± 0.41 * | 6.68 ± 0.46 | 7.10 ± 0.54 * | 6.33 ± 0.68 | 7.03 ± 0.43 * |
| Work (kJ) | 12.22 ± 1.07 | 13.14 ± 1.93 * | 13.41 ± 2.80 | 15.13 ± 2.41 * | 13.29 ± 1.37 | 14.55 ± 1.49 * | 12.80 ± 1.67 | 14.08 ± 2.08 * |
| Sprint Decrement (%) | 65.47 ± 9.65 | 72.24 ± 9.07 | 67.52 ± 9.21 | 68.36 ± 5.97 | 68.38 ± 3.45 | 70.55 ± 5.73 | 64.06 ± 7.69 | 64.98 ± 6.62 |
| sDec (%) | 16.63 ± 7.24 | 11.52 ± 2.74 * | 21.02 ± 5.97 | 13.49 ± 5.94 * | 20.14 ± 6.39 | 14.30 ± 3.74 * | 15.30 ± 6.91 | 11.85 ± 5.95 * |
| Average of Pre Sprint MPA | 4.25 ± 0.85 | 2.05 ± 1.11 * | 4.07 ± 1.37 | 3.01 ± 1.15 * | 4.48 ± 2.33 | 3.14 ± 1.47 * | 4.81 ± 1.21 | 2.89 ± 1.02 * |
| Average of Post Sprint MPA | 6.91 ± 1.52 | 4.18 ± 1.40 * | 6.80 ± 1.05 | 5.58 ± 1.91 * | 5.52 ± 1.57 | 4.16 ± 2.00 * | 6.78 ± 1.11 | 4.82 ± 1.29 * |
| Average of Pre Sprint RPE | 12.50 ± 1.18 | 9.17 ± 2.20 * | 12.65 ± 1.48 | 11.34 ± 1.61 * | 12.04 ± 2.43 | 10.43 ± 2.39 * | 13.97 ± 1.77 | 10.71 ± 1.89 * |
| Average of Post Sprint RPE | 16.15 ± 2.30 | 13.00 ± 2.25 * | 17.40 ± 1.64 | 15.46 ± 1.52 * | 15.26 ± 2.80 | 14.00 ± 3.12 * | 15.96 ± 1.06 | 14.31 ± 1.76 * |
| Average of Pre Sprint HR | 144.90 ± 7.68 | 134.09 ± 11.38 | 145.75 ± 15.70 | 146.21 ± 10.99 | 142.30 ± 11.81 | 140.38 ± 7.86 | 143.28 ± 10.86 | 140.80 ± 14.95 |
| Average of Post Sprint HR | 185.09 ± 5.82 | 179.71 ± 6.09 | 184.22 ± 9.78 | 186.34 ± 7.25 | 183.31 ± 5.24 | 184.02 ± 5.67 | 184.18 ± 6.73 | 182.50 ± 10.40 |
| Critical Power (w) | 162.95 ± 29.15 | 198.98 ± 29.90 * | 180.11 ± 38.41 | 205.67 ± 33.84 * | 175.87 ± 34.34 | 205.09 ± 32.79 * | 169.24 ± 43.71 | 196.04 ± 24.07 * |
PP: peak power; MP: mean power; sDec: sprint decrement; MPA: muscle pain; RPE: ratings of perceived exertion; HR: heart rate; RPE: ratings of perceived exertion. *: significant difference between pre and post test p < 0.05.
Figure 4Repeated wingate test. PP: peak power, MP: mean power, *: significant difference between pre and post test.
Figure 5Critical power test. CP: critical power, *: significant difference between pre and post test.
Average of 4 weeks (12 sessions in total) of training parameters.
| Parameters | 15 H | 15 N | 30 H | 30 N |
|---|---|---|---|---|
| PP (w/kg) | 10.54 ± 0.95 | 10.87 ± 1.18 | 9.91 ± 1.27 | 9.97 ± 0.79 |
| MP (w/kg) | 8.21 ± 0.54 * | 8.30 ± 0.62 * | 6.66 ± 0.56 | 6.54 ± 0.43 |
| Sprint Decrement (%) | 47.08 ± 9.01 | 47.86 ± 9.89 | 68.96 ± 4.97 # | 65.40 ± 4.09 # |
| sDec (%) | 10.65 ± 2.56 | 10.76 ± 2.27 | 16.53 ± 2.85 # | 14.79 ± 2.68 # |
| Work (kJ) | 8.07 ± 1.21 | 9.14 ± 1.49 | 13.51 ± 1.51 # | 13.09 ± 1.74 # |
| Average of Pre Sprint MPA | 2.67 ± 0.67 | 2.84 ± 0.90 | 3.14 ± 0.77 | 2.82 ± 1.23 |
| Average of Post Sprint MPA | 4.43 ± 1.22 | 4.67 ± 1.34 | 5.01 ± 1.14 | 4.48 ± 1.31 |
| Average of Pre Sprint RPE | 9.93 ± 1.65 | 10.62 ± 1.22 | 11.12 ± 1.75 | 10.88 ± 2.08 |
| Average of Post Sprint RPE | 12.80 ± 2.35 | 13.81 ± 1.79 | 15.00 ± 1.72 | 14.09 ± 1.81 |
| Average of Pre Sprint HR (beats/min) | 143.48 ± 10.0 | 143.68 ± 11.7 | 142.39 ± 6.92 | 140.36 ± 12.1 |
| Average of Post Sprint HR (beats/min) | 173.91 ± 6.30 | 175.11 ± 8.90 | 180.23 ± 5.36 | 180.93 ± 9.41 |
| Average of Pre Sprint SpO2 (%) | 84.71 ± 3.11 $ | 92.26 ± 1.36 | 83.9 ± 2.51 $ | 91.67 ± 1.91 |
| Average of Post Sprint SpO2 (%) | 83.97 ± 2.58 $ | 90.61 ± 1.04 | 83.59 ± 1.72 $ | 90.16 ± 1.87 |
PP: peak power; MP: mean power; sDec: sprint decrement; MPA: muscle pain; RPE: ratings of perceived exertion; HR: heart rate; SpO2: arterial oxygen saturation; *: significantly different from 30 H and 30 N; #: significantly different from 15 H and 15 N; $: significantly different from normoxia groups.